Jason Haas serves as Executive at LIGAND PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Jason Haas has executed 13 insider transactions totaling $161.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 12, 2024 involved purchasing 45,344 shares valued at $76.2K.
Jason Haas currently holds 124,552 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Haas has been a net buyer of LGND stock. They have purchased $161.5K and sold $0 worth of shares.
Jason Haas's most recent insider trade was on Sep 12, 2024, when they purchased 45,344 shares at $1.68 per share.
Get notified when new Form 4 filings are submitted
| $1.58 |
| Discretionary |
| Sep 10, 2024 | SYRS | $54.8K | Purchase | 35,363 | $1.55 | Discretionary |
| Jun 14, 2024 | LGND | $0 | Award | 1,252 | $N/A | Discretionary |
| Apr 1, 2024 | SYRS | $24.2K | Payment | 4,732 | $5.12 | Discretionary |
| Mar 31, 2024 | SYRS | $0 | Option Exercise | 2,000 | $N/A | Discretionary |
| Mar 31, 2024 | SYRS | $0 | Option Exercise | 13,333 | $N/A | Discretionary |
| Nov 1, 2023 | SYRS | $14.0K | Payment | 6,301 | $2.22 | Discretionary |
| Oct 31, 2023 | SYRS | $0 | Option Exercise | 18,875 | $N/A | Discretionary |
| Jun 9, 2023 | LGND | $0 | Award | 1,142 | $N/A | Discretionary |
| Apr 3, 2023 | SYRS | $1.6K | Payment | 623 | $2.58 | Discretionary |
| Mar 31, 2023 | SYRS | $0 | Option Exercise | 2,000 | $N/A | Discretionary |
| Jun 29, 2022 | LGND | $0 | Award | 1,750 | $N/A | Discretionary |